ELYM (eliemtx.com) Bozor qiymatining balans qiymatiga nisbati
Neyrobiologiya sohasi Eliem Therapeutics (ELYM) uchun ulkan ilmiy qiyinchiliklar va global raqobatni o'z ichiga oladi. Nisbiy bozor kapitalizatsiyasi baholash ko'rsatkichi ushbu xavflarni baholashga yordam beradi, bunda 1.54 indikatorning joriy darajasi vazifasini o'taydi. Ushbu tendentsiya sinovlar uchun xomashyolarning optimallashtirilgan ta'minotiga tayanadi, strategiyaning muvaffaqiyati esa depressiya va surunkali og'riqlar uchun xavfsiz davolash usullarini yaratishga asoslangan.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ELYM_-_Eliem-Therapeutics_-_Capitalization-to-Book-Value-Ratio "ELYM Eliem Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 03.10.2024) | 👁️GURU.Markets👁️")
Eliem Therapeutics (ELYM) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati eliemtx.com|ELYM - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Eliem|ELYM - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Eliem Therapeutics
Kompaniyaning dastlabki tahlili:Eliem Therapeutics, Inc.
Eliem Therapeutics (ELYM) uchun ushbu ko'rsatkich bozor qiymatini sof aktivlarga solishtirib, asab tizimi dori vositalarining potentsial ishlab chiqilishi uchun qo'shimcha qiymatni ochib beradi. Ushbu metrika bozor kapitalizatsiyasining balans qiymatiga nisbati sifatida hisoblanadi va balans qiymati bilan investorlar kutimlari o'rtasidagi farqni o'lchaydi. Bozor qiymatining balans qiymatidan bir necha baravar yuqori bo'lgan tarixini tahlil qilish orqali klinik risklarning kotirovkalarga ta'sirini baholash mumkin. Yuqori qiymatlar kelajakdagi mahsulotlarga nisbatan spekulyativ optimizmni aks ettiradi, haddan tashqari katta farq esa kapitalning muzlab qolish xavfi haqida signal beradi.
Toʻgʻridan-toʻgʻri raqobatchilar
BIIB (Biogen Inc.) - Bozor qiymatining balans qiymatiga nisbati|NBIX (neurocrine.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AMLX (Amylyx Pharmaceuticals)|Bozor qiymatining balans qiymatiga koeffitsiyenti TRVI|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|Bozor qiymatining balans qiymatiga nisbati Anavex (AVXL)|Bozor kapitallashuvining balans qiymatiga nisbati CBLL|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena PRTA|ALEC (Alector Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga koeffitsiyenti|OMER (omeros.com) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Neurogene Inc|ACIU - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Voyager Corp (VYGR)|Kapitallashuvning sof aktivlarga nisbati Neumora Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori scilexholding.com (SCLX)|Bozor kapitallashuvining balans qiymatiga nisbati Tevogen Bio|Balans qiymatiga nisbatan bozor qiymati Alpha Cognition Inc ACOG|CGTX (Cognition Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IKT: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Cassava Sciences, Inc. SAVA|Assertio (ASRT) - Balans qiymatiga nisbatan bozor qiymati|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VTGN|OVID - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Acumen Pharmaceuticals, Inc (ABOS)|CRVO: Bozor kapitallashuvining balans qiymatiga nisbati|ATHE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Clene Nanomedicine - Kapitallashuvning sof aktivlarga nisbati|PepGen Inc. (PEPG) - Bozor kapitallashuvining balans qiymatiga nisbati|JUNS - Kapitallashuvning sof aktivlarga nisbati|Relmada Corp (RLMD) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ANVS: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Grace Tx|Bozor kapitallashuvining balans qiymatiga nisbati AIFF (Firefly Neuroscience)|Kapitallashuvning sof aktivlarga nisbati KLTO (anewmeds.com)|Bozor qiymatining balans qiymatiga nisbati NRSN|Balans qiymatiga nisbatan bozor kapitallashuvi Reviva Pharmaceuticals, Inc. RVPH|MTVA (MetaVia, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|NRXS: Bozor qiymatining balans qiymatiga koeffitsiyenti|heliusmedical.com (HSDT) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Passage Bio|Kapitallashuvning sof aktivlarga nisbati NEUP (Neuphoria Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti NERV|Bozor qiymatining balans qiymatiga nisbati ATHA (Athira Pharma, Inc.)|Kapitallashuvning sof aktivlarga nisbati ADXN (addextherapeutics.com)|ALZN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Cyclerion Therapeutics Inc. CYCN|PTIX (Protagenic) - Bozor kapitallashuvining balans qiymatiga nisbati|Pasithea Therapeutics (KTTA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CRGT: Kapitallashuvning sof aktivlarga nisbati|ATXI (avenuetx.com) - Bozor kapitallashuvining balans qiymatiga nisbati|BCLI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CARA|Chromocell Therapeutics Corporation - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com (ITCI)|LBPH: Bozor kapitallashuvining balans qiymatiga nisbati|marinuspharma.com - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGN - Bozor qiymatining balans qiymatiga nisbati|NRBO - Bozor qiymatining balans qiymatiga nisbati|Sage Therapeutics, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Synaptogenix, Inc (SNPX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati TRVN (Trevena, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti VIGL|Bozor qiymatining balans qiymatiga nisbati WENA (Anew Medical, Inc.)|Kapitallashuvning sof aktivlarga nisbati Cerevel Therapeutics Inc CERE